drugset / Trial / NCT00990613

A Study Evaluating The Absorption Of Dimebon Into The Body From A Dimebon Solution Applied To The Skin

NCT00990613

Phase 1 Completed 19 enrolled Pfizer Medivation, Inc. · collab
RandomizedCrossoverDouble-blind

Summary

To estimate the absorption, safety, and tolerability of a dimebon transdermal solution relative to the dimebon immediate release oral formulation.

Timeline

Start
2009-10
Primary completion
2010-01
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Latrepirdine Small molecule 5 mg Oral
Subject Latrepirdine Small molecule 10 mg Oral